Oramed Pharmaceuticals
ORMP
#8959
Rank
NZ$0.26 B
Marketcap
NZ$6.61
Share price
1.30%
Change (1 day)
71.78%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): NZ$98.84 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are NZ$2 Million. In 2024 the company made an earning of -NZ$25.54 Million a decrease over its 2023 earnings that were of NZ$12.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$98.84 M-487.17%
2024 -NZ$25.54 Million-311.47%
2023 NZ$12.07 M-119.45%
2022 -NZ$62.07 Million39.17%
2021 -NZ$44.6 Million73.93%
2020 -NZ$25.65 Million18.53%
2019 -NZ$21.64 Million-16.62%
2018 -NZ$25.95 Million38.32%
2017 -NZ$18.76 Million12.51%
2016 -NZ$16.68 Million25.01%
2015 -NZ$13.34 Million18.18%
2014 -NZ$11.29 Million39.72%
2013 -NZ$8.08 Million46.4%
2012 -NZ$5.52 Million128.32%
2011 -NZ$2.42 Million-51.47%
2010 -NZ$4.98 Million35.21%
2009 -NZ$3.69 Million
2007 -NZ$5.8 Million607.04%
2006 -NZ$0.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
NZ$35.51 B 35,853.48%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$13.04 B 13,105.89%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.87 Billion-973.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-NZ$46.71 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel